Position in MRK
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$5,839,085,616
+$484,254,776 QoQ
Shares Held
45,440,355
+2.1% QoQ
Ownership
1.84%
of shares outstanding
% of Portfolio
0.27%
of 13F equity value
Holder Rank
#9
of 3,769 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 71%
Shared 0%
None 29%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026FMR LLC holds $75,393,052,380 across 17 Drug Manufacturers - General names. MRK ranks #3 (7.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
28,462,475 | $34,138,749,234 | |
| 2 | GILD |
Gilead Sciences, Inc.
|
66,870,816 | $8,448,458,890 | |
| 3 | MRK |
Merck & Co., Inc.
This page
|
45,440,355 | $5,839,085,616 | |
| 4 | JNJ |
Johnson & Johnson
|
22,595,566 | $5,738,595,894 | |
| 5 | AZN |
Astrazeneca PLC
|
28,895,264 | $5,479,119,956 | |
| 6 | ABBV |
AbbVie Inc.
|
20,773,786 | $5,227,515,506 | |
| 7 | BIIB |
Biogen Inc.
|
18,217,239 | $3,936,016,655 | |
| 8 | GSK |
GSK plc
|
64,961,641 | $3,405,289,219 |
All Filings in MRK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,839,085,616 | 45,440,355 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $5,354,830,840 | 44,516,010 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $4,298,456,935 | 40,836,566 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $2,805,507,125 | 33,426,750 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $2,498,774,452 | 31,566,125 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $2,855,089,937 | 31,808,043 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $3,716,629,699 | 37,360,572 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $5,644,647,879 | 49,706,304 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $6,270,872,842 | 50,653,254 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $6,883,952,758 | 52,170,919 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $4,666,057,851 | 42,800,017 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $3,927,048,131 | 38,145,198 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $4,496,130,499 | 38,964,646 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $3,801,838,668 | 35,734,925 | Shares | Defined | 2023-08-11 | |
| 2022-12-31 | $3,045,908,460 | 27,452,983 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $1,997,729,083 | 23,197,040 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $2,037,608,380 | 22,349,549 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $1,192,439,128 | 14,533,079 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $1,078,324,873 | 14,070,001 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $802,766,813 | 10,687,882 | Shares | Defined | 2022-02-14 | |
| 2021-06-30 | $805,531,782 | 10,357,873 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $477,365,280 | 6,192,308 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $623,327,332 | 7,620,142 | Shares | Defined | 2021-02-08 | |
| 2020-09-30 | $1,006,990,570 | 12,139,724 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $1,002,015,740 | 12,957,653 | Shares | Defined | 2020-08-24 | |
| 2020-03-31 | $993,752,546 | 12,915,947 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||